NEW YORK (GenomeWeb News) – Liverpool, UK-based Biofortuna announced today that it has extended an exclusive distribution agreement with Abbott.
Under the new agreement, Abbott will distribute Biofortuna's SSPGo range of freeze dried HLA typing kits in France, Spain, Portugal, and the Benelux countries. With this new agreement, Abbott now has exclusive rights to distribute the kits, along with the Verdict interpretation software, in all global territories.
The firms inked the initial distribution pact last year, but at that time the deal excluded the territories covered in the agreement announced today.
Biofortuna's freeze-drying capabilities enable PCR diagnostic kits to be stable at ambient temperature for up to 16 months.